Effect of route of administration of immunosuppression by DMBA in CBA mice.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001551:Benz(a)Anthracenes / Q000008:administration & dosage*; D002273:Carcinogens / Q000008:administration & dosage*; D004912:Erythrocytes; D005260:Female; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D051379:Mice
D001551:Benz(a)Anthracenes; D002273:Carcinogens; D007166:Immunosuppressive Agents